Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II placebo-controlled trial of Org 3236 in men with LUTS suggestive of BPH
NL-OMON31439Phase 2Not yet recruiting
- Sponsor
- Organon & Co.
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Org 3236 with Placebo (2 arms). Primary endpoints: Prostate volume, PSA and 8 more. Planned start Mar 2008; status: not yet recruiting.
02
Drugs
etonogestrel
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NL-OMON31439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31439.